These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
410 related articles for article (PubMed ID: 20166112)
21. [Adrenoleukodystrophy: structure and function of ALDP, and intracellular behavior of mutant ALDP with naturally occurring missense mutations]. Takahashi N; Morita M; Imanaka T Yakugaku Zasshi; 2007 Jan; 127(1):163-72. PubMed ID: 17202797 [TBL] [Abstract][Full Text] [Related]
22. ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy. Baarine M; Beeson C; Singh A; Singh I J Neurochem; 2015 May; 133(3):380-96. PubMed ID: 25393703 [TBL] [Abstract][Full Text] [Related]
23. The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters. van Roermund CW; Visser WF; Ijlst L; van Cruchten A; Boek M; Kulik W; Waterham HR; Wanders RJ FASEB J; 2008 Dec; 22(12):4201-8. PubMed ID: 18757502 [TBL] [Abstract][Full Text] [Related]
24. Astrocytes and mitochondria from adrenoleukodystrophy protein (ABCD1)-deficient mice reveal that the adrenoleukodystrophy-associated very long-chain fatty acids target several cellular energy-dependent functions. Kruska N; Schönfeld P; Pujol A; Reiser G Biochim Biophys Acta; 2015 May; 1852(5):925-36. PubMed ID: 25583114 [TBL] [Abstract][Full Text] [Related]
25. Contiguous deletion of the X-linked adrenoleukodystrophy gene (ABCD1) and DXS1357E: a novel neonatal phenotype similar to peroxisomal biogenesis disorders. Corzo D; Gibson W; Johnson K; Mitchell G; LePage G; Cox GF; Casey R; Zeiss C; Tyson H; Cutting GR; Raymond GV; Smith KD; Watkins PA; Moser AB; Moser HW; Steinberg SJ Am J Hum Genet; 2002 Jun; 70(6):1520-31. PubMed ID: 11992258 [TBL] [Abstract][Full Text] [Related]
26. Induction of peroxisomal lipid metabolism in mice fed a high-fat diet. Kozawa S; Honda A; Kajiwara N; Takemoto Y; Nagase T; Nikami H; Okano Y; Nakashima S; Shimozawa N Mol Med Rep; 2011; 4(6):1157-62. PubMed ID: 21850377 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy. McGuinness MC; Zhang HP; Smith KD Mol Genet Metab; 2001; 74(1-2):256-63. PubMed ID: 11592822 [TBL] [Abstract][Full Text] [Related]
29. A very long-chain acyl-CoA synthetase-deficient mouse and its relevance to X-linked adrenoleukodystrophy. Heinzer AK; Watkins PA; Lu JF; Kemp S; Moser AB; Li YY; Mihalik S; Powers JM; Smith KD Hum Mol Genet; 2003 May; 12(10):1145-54. PubMed ID: 12719378 [TBL] [Abstract][Full Text] [Related]
30. Mutational and protein analysis of patients and heterozygous women with X-linked adrenoleukodystrophy. Feigenbaum V; Lombard-Platet G; Guidoux S; Sarde CO; Mandel JL; Aubourg P Am J Hum Genet; 1996 Jun; 58(6):1135-44. PubMed ID: 8651290 [TBL] [Abstract][Full Text] [Related]
31. Lorenzo's oil inhibits ELOVL1 and lowers the level of sphingomyelin with a saturated very long-chain fatty acid. Sassa T; Wakashima T; Ohno Y; Kihara A J Lipid Res; 2014 Mar; 55(3):524-30. PubMed ID: 24489110 [TBL] [Abstract][Full Text] [Related]
32. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment. Kemp S; Wanders RJ Mol Genet Metab; 2007 Mar; 90(3):268-76. PubMed ID: 17092750 [TBL] [Abstract][Full Text] [Related]
33. Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy. Netik A; Forss-Petter S; Holzinger A; Molzer B; Unterrainer G; Berger J Hum Mol Genet; 1999 May; 8(5):907-13. PubMed ID: 10196381 [TBL] [Abstract][Full Text] [Related]
34. Probing substrate-induced conformational alterations in adrenoleukodystrophy protein by proteolysis. Guimarães CP; Sá-Miranda C; Azevedo JE J Hum Genet; 2005; 50(2):99-105. PubMed ID: 15682271 [TBL] [Abstract][Full Text] [Related]